GOVERNMENT CRACKDOWN ON FAKE DRUGS CONTINUES
| BY
clpstaff &clp articlesLast week the Guangzhou Tainhe district court ruled against four defendants who were involved in a fake drugs scandal which lead to the death of 14 people.…
Last week the Guangzhou Tainhe district court ruled against four defendants who were involved in a fake drugs scandal which lead to the death of 14 people. The lawsuit was filed in March 2007 and accused the defendants (three pharmaceutical companies and a hospital) of producing and selling counterfeit drugs.
The courts ordered the defendants (Qiqihar No 2 Pharmaceutical Co Ltd, the Third Affiliated Hospital of Guangzhou Sun Yat-sen University, Guangdong Health Care Goods Co, and Guangzhou Jinhengyuan Medicine Trading Co) to pay a total of Rmb 3.5 million (US$509,800) to 11 plaintiffs. The compensation was calculated to cover the plaintiffs' medical expenses and damages for mental suffering, the court said. According to Chen Beiyuan, the attorney for one of the plaintiffs, this was “the highest compensation we could have achieved under the existing law.”
This premium content is reserved for
China Law & Practice Subscribers.
A Premium Subscription Provides:
- A database of over 3,000 essential documents including key PRC legislation translated into English
- A choice of newsletters to alert you to changes affecting your business including sector specific updates
- Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
Already a subscriber? Log In Now